NasdaqGS - Delayed Quote • USD
Ovid Therapeutics Inc. (OVID)
At close: April 18 at 4:00 PM EDT
After hours: April 18 at 6:33 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-45,780.9250
-45,780.9250
-55,227.1270
118,611.6730
-51,583.9140
Investing Cash Flow
-2,580.6050
-2,580.6050
-87,883.2170
-1,821.4000
34,648.2280
Financing Cash Flow
30,535.2010
30,535.2010
180.6580
904.0820
47,072.4720
End Cash Position
28,972.2700
28,972.2700
46,798.5990
189,728.2850
72,033.9300
Capital Expenditure
-137.4550
-137.4550
-1,418.7760
-189.4080
-390.6800
Issuance of Capital Stock
--
--
--
--
46,731.4350
Free Cash Flow
-45,918.3800
-45,918.3800
-56,645.9030
118,422.2650
-51,974.5940
12/31/2020 - 5/5/2017
Yahoo Finance Plus Essential access required. Unlock Access
Related Tickers
KZIA Kazia Therapeutics Limited
0.3462
+0.90%
TRDA Entrada Therapeutics, Inc.
11.91
-2.54%
ARTL Artelo Biosciences, Inc.
1.2800
-1.54%
INVA Innoviva, Inc.
14.69
+1.45%
PHGE BiomX Inc.
0.2958
+5.61%
NXTC NextCure, Inc.
1.5700
+3.97%
EQ Equillium, Inc.
1.7300
-3.35%
NRSNW NeuroSense Therapeutics Ltd.
0.2500
0.00%
KTTA Pasithea Therapeutics Corp.
7.15
0.00%
TRVI Trevi Therapeutics, Inc.
2.6850
+4.07%